These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29413285)

  • 1. Normal Tissue Complication Probability Modeling of Pulmonary Toxicity After Stereotactic and Hypofractionated Radiation Therapy for Central Lung Tumors.
    Tekatli H; Duijm M; Oomen-de Hoop E; Verbakel W; Schillemans W; Slotman BJ; Nuyttens JJ; Senan S
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):738-747. PubMed ID: 29413285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting High-Grade Esophagus Toxicity After Treating Central Lung Tumors With Stereotactic Radiation Therapy Using a Normal Tissue Complication Probability Model.
    Duijm M; van der Voort van Zyp NC; van de Vaart P; Oomen-de Hoop E; Mast ME; Hoogeman MS; Nuyttens JJ
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):73-81. PubMed ID: 31499137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophagus toxicity after stereotactic and hypofractionated radiotherapy for central lung tumors: Normal tissue complication probability modeling.
    Duijm M; Tekatli H; Oomen-de Hoop E; Verbakel W; Schillemans W; Slotman BJ; Senan S; Nuyttens JJ
    Radiother Oncol; 2018 May; 127(2):233-238. PubMed ID: 29478763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective cohort study of bronchial doses and radiation-induced atelectasis after stereotactic body radiation therapy of lung tumors located close to the bronchial tree.
    Karlsson K; Nyman J; Baumann P; Wersäll P; Drugge N; Gagliardi G; Johansson KA; Persson JO; Rutkowska E; Tullgren O; Lax I
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):590-5. PubMed ID: 24074933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
    Murrell DH; Laba JM; Erickson A; Millman B; Palma DA; Louie AV
    Radiat Oncol; 2018 Apr; 13(1):57. PubMed ID: 29606150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
    Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy.
    Modh A; Rimner A; Williams E; Foster A; Shah M; Shi W; Zhang Z; Gelblum DY; Rosenzweig KE; Yorke ED; Jackson A; Wu AJ
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1168-76. PubMed ID: 25303891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation-induced brachial plexus toxicity after SBRT of apically located lung lesions.
    Lindberg K; Grozman V; Lindberg S; Onjukka E; Lax I; Lewensohn R; Wersäll P
    Acta Oncol; 2019 Aug; 58(8):1178-1186. PubMed ID: 31066326
    [No Abstract]   [Full Text] [Related]  

  • 9. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
    Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity after central versus peripheral lung stereotactic body radiation therapy: a propensity score matched-pair analysis.
    Mangona VS; Aneese AM; Marina O; Hymas RV; Ionascu D; Robertson JM; Gallardo LJ; Grills IS
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):124-32. PubMed ID: 25442337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-Volume Predictors of Esophagitis After Thoracic Stereotactic Body Radiation Therapy.
    Harder EM; Chen ZJ; Park HS; Mancini BR; Decker RH
    Am J Clin Oncol; 2017 Oct; 40(5):477-482. PubMed ID: 26017483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose and Volume of the Irradiated Main Bronchi and Related Side Effects in the Treatment of Central Lung Tumors With Stereotactic Radiotherapy.
    Duijm M; Schillemans W; Aerts JG; Heijmen B; Nuyttens JJ
    Semin Radiat Oncol; 2016 Apr; 26(2):140-8. PubMed ID: 27000511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of RTOG 0813 Proximal Bronchial Tree Constraints for Pulmonary Toxicity With Stereotactic Body Radiation Therapy for Central Non-small Cell Lung Cancer.
    Manyam BV; Verdecchia K; Videtic GMM; Zhuang T; Woody NM; Wei W; Ouyang Z; Stephans KL
    Int J Radiat Oncol Biol Phys; 2020 May; 107(1):72-78. PubMed ID: 31987965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central Airway Toxicity After High Dose Radiation: A Combined Analysis of Prospective Clinical Trials for Non-Small Cell Lung Cancer.
    Wang W; Matuszak MM; Hu C; Huang KC; Chen E; Arenberg D; Curtis JL; Jolly S; Jin JY; Machtay M; Ten Haken RK; Kong FS
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):587-596. PubMed ID: 32470501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchial Stenosis in Central Pulmonary Tumors Treated With Stereotactic Body Radiation Therapy.
    Rijksen BLT; Rossi MMG; Walraven I; Stam B; Knegjens JL; van Diessen JNA; Lalezari F; Sonke JJ; Belderbos JSA
    Pract Radiat Oncol; 2022; 12(5):e382-e392. PubMed ID: 35452867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.
    Stephans KL; Djemil T; Diaconu C; Reddy CA; Xia P; Woody NM; Greskovich J; Makkar V; Videtic GM
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):197-202. PubMed ID: 25015204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus.
    Song SY; Choi W; Shin SS; Lee SW; Ahn SD; Kim JH; Je HU; Park CI; Lee JS; Choi EK
    Lung Cancer; 2009 Oct; 66(1):89-93. PubMed ID: 19168260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4π noncoplanar stereotactic body radiation therapy for centrally located or larger lung tumors.
    Dong P; Lee P; Ruan D; Long T; Romeijn E; Low DA; Kupelian P; Abraham J; Yang Y; Sheng K
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):407-13. PubMed ID: 23523322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicities of organs at risk in the mediastinal and hilar regions following stereotactic body radiotherapy for centrally located lung tumors.
    Nishimura S; Takeda A; Sanuki N; Ishikura S; Oku Y; Aoki Y; Kunieda E; Shigematsu N
    J Thorac Oncol; 2014 Sep; 9(9):1370-6. PubMed ID: 25122433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.